
Accelerating drug discovery and development through generative AI and automation for longevity and sustainability.
Visit WebsiteInsilico Medicine (ai research): Accelerating drug discovery and development through generative AI and automation for longevity and sustainability. Insilico Medicine is an end-to-end generative AI-driven biotech company that transforms drug discovery and development. It leverages its proprietary Pharma.AI platform, which encompasses biology, chemistry, and clinical development, to significantly reduce the time and cost associated with bringing new medications to patients. Key capabilities: Generative AI for target identification and novel molecule design, Automation for drug discovery and development processes, Proprietary Pharma.AI platform (biology, chemistry, clinical development), PandaOmics for target discovery and drug repurposing, Chemistry42 for de novo molecular design. Insilico Medicine is paid-only, with most plans including a trial period. Buyers most often compare Insilico Medicine against Hugging Face, Mistral AI, Starget Pharma.
Pros
Cons
Insilico Medicine offers paid plans. Visit their website for current pricing details.
Be the first to review Insilico Medicine
Your take helps the next buyer. Verified LinkedIn reviewers get a badge.
Write a reviewTop alternatives based on features, pricing, and user needs.
AI community and platform
Open AI models
Developing Smart Targeted Radioligands for precision oncology using an AI-driven discovery engine.
Translating scientific discoveries into medical solutions for patients.
Developing breakthrough therapies for rare diseases with high unmet medical needs.
Developing inhaled therapeutics for severe respiratory diseases.
Developing innovative therapies for chronic and debilitating diseases.
Developing novel small molecule therapeutics for life-threatening diseases.
Source: insilico.com